Form 4: Arteris CEO Sells 11,145 Shares Under 10b5-1 Plan

Arteris, Inc. President and CEO, K. Charles Janac, reported the sale of 11,145 shares of common stock for approximately $188,380 under a pre-arranged 10b5-1 trading plan.

Summary

• K. Charles Janac, President and CEO, Director, and 10% Owner of Arteris, Inc. (AIP), sold 11,145 shares of common stock.
• The transaction occurred on January 6, 2026, at a weighted average price of $16.9032 per share, totaling approximately $188,380.
• The shares were sold in multiple transactions ranging from $15.86 to $17.65.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Janac on March 5, 2025.
• Following the transaction, Mr. Janac directly beneficially owns 139,487 shares of common stock.
• Indirect beneficial ownership includes 9,469,071 shares through Bayview Legacy, LLC, and 56,252 shares through the Charles and Lydia Janac Trust.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to an insider sale by the CEO. However, the negative impact is mitigated by the fact that the sale was pre-planned under a 10b5-1 plan and represents a relatively small portion of the CEO's total beneficial ownership, preventing a lower score.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which was adopted well in advance on March 5, 2025, indicating the transaction was not based on immediate, non-public information.
• The number of shares sold (11,145) represents a relatively small fraction of Mr. Janac's total beneficial ownership, which still includes over 9.6 million shares directly and indirectly.

Negatives

• A key insider, who is the President and CEO, a Director, and a 10% owner, reduced their direct ownership in the company.
• While pre-planned, an insider sale can sometimes be perceived as a lack of confidence in the company's near-term stock performance by some investors.

Future Outlook

This Form 4 filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, such as this sale by a CEO, are common occurrences in publicly traded companies. While a sale can sometimes be viewed negatively, the use of a 10b5-1 plan is a standard practice for executives to diversify holdings or manage liquidity without being accused of trading on inside information. The impact on industry trends or competitors is not directly addressed by this specific filing.

Stakeholder Impact

• Shareholders may perceive the insider sale as a slight negative signal, potentially leading to increased scrutiny of the company's future performance and management's confidence.
• Employees, customers, suppliers, and creditors are unlikely to be directly impacted by this specific insider transaction report.

Key Dates

Recommendation

While an insider sale by the CEO is generally a negative signal, the transaction was executed under a pre-arranged 10b5-1 plan, which reduces the implication of trading on immediate non-public information. The amount sold is also a small percentage of the CEO's total beneficial ownership. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor future insider activity and company performance rather than making an immediate 'sell' decision based solely on this single, pre-planned transaction.

Keywords

Arteris, AIP, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Beneficial Ownership